MX2009013115A - Derivados de prolinamida como antagonistas de nk3. - Google Patents
Derivados de prolinamida como antagonistas de nk3.Info
- Publication number
- MX2009013115A MX2009013115A MX2009013115A MX2009013115A MX2009013115A MX 2009013115 A MX2009013115 A MX 2009013115A MX 2009013115 A MX2009013115 A MX 2009013115A MX 2009013115 A MX2009013115 A MX 2009013115A MX 2009013115 A MX2009013115 A MX 2009013115A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- lower alkyl
- hydrogen
- halogen
- substituted
- Prior art date
Links
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical class NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical class 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 abstract 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Abstract
La presente invención se refiere a un compuesto de fórmula (I) en donde R1 es hidrógeno, halógeno, alquilo inferior, alquilo inferior sustituido por halógeno, alcoxi inferior, o alcoxi inferior sustituido por halógeno; R2 es hidrógeno o alquilo inferior; R3, R4 forman conjuntamente con el átomo de N al cual se unen un grupo heterocíclico no aromático, seleccionado de R5 es hidrógeno o halógeno; R6 es fenilo, insustituido o sustituido por ciano, halógeno, alquilo inferior, alcoxi inferior, CF3, -(CH2)20-alquilo inferior, C(O)-alquilo inferior o C(O)O-alquilo inferior, o es piridinilo, insustituido o sustituido por CF3, o es -C(O)-fenilo; R7 es hidrógeno o alquilo inferior; R8 es fenilo, alquilo inferior o -C(O)O-alquilo inferior; R9 es hidrógeno o S(O)2-alquilo inferior; R10 es hidrógeno o cicloalquilo; X es -CH2- o -C(O)-; p es 1 o 2; n es 1, 2 o 3; o es 1 o 2; o a una sal de adición de ácido farmacéuticamente adecuada del mismo, los cuales son altos antagonistas del receptor de NK-3 potenciales para el tratamiento de depresión, dolor, psicosis, enfermedad de Parkinson, esquizofrenia, ansiedad y trastorno de hiperactividad por déficit de atención (ADHD).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109781 | 2007-06-07 | ||
| PCT/EP2008/056589 WO2008148689A1 (en) | 2007-06-07 | 2008-05-29 | Prolinamide derivatives as nk3 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013115A true MX2009013115A (es) | 2010-01-15 |
Family
ID=39639487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013115A MX2009013115A (es) | 2007-06-07 | 2008-05-29 | Derivados de prolinamida como antagonistas de nk3. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7528136B2 (es) |
| EP (1) | EP2155672B1 (es) |
| JP (1) | JP2010529069A (es) |
| KR (1) | KR101163292B1 (es) |
| CN (1) | CN101679241B (es) |
| AT (1) | ATE486058T1 (es) |
| AU (1) | AU2008258665B2 (es) |
| BR (1) | BRPI0812447A2 (es) |
| CA (1) | CA2689560A1 (es) |
| DE (1) | DE602008003221D1 (es) |
| ES (1) | ES2351378T3 (es) |
| IL (1) | IL202236A0 (es) |
| MX (1) | MX2009013115A (es) |
| WO (1) | WO2008148689A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010126030A1 (ja) * | 2009-04-28 | 2010-11-04 | 中外製薬株式会社 | スピロイミダゾロン誘導体 |
| US8314250B2 (en) | 2009-11-24 | 2012-11-20 | Hoffmann-La Roche Inc. | Sultam derivatives |
| US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
| US9073881B2 (en) | 2011-09-23 | 2015-07-07 | Hoffmann-La Roche Inc. | Benzoic acid derivatives |
| US9090559B2 (en) | 2012-02-24 | 2015-07-28 | Hoffmann-La Roche Inc. | Antiviral compounds |
| NO2930176T3 (es) | 2012-12-10 | 2018-07-07 | ||
| RU2701168C2 (ru) | 2014-06-09 | 2019-09-25 | Чугаи Сейяку Кабусики Кайся | Фармацевтическая композиция, содержащая производные гидантоина |
| CN105153005A (zh) * | 2015-08-05 | 2015-12-16 | 上海瑞博化学有限公司 | 一种4-羰基-脯氨酸衍生物的制备方法 |
| US11491136B2 (en) | 2017-02-14 | 2022-11-08 | Research Triangle Institute | Proline-based neuropeptide FF receptor modulators |
| KR102453438B1 (ko) | 2020-06-15 | 2022-10-12 | 주식회사 한중엔시에스 | 리저버 일체형 진공 펌프 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1169731A (zh) * | 1994-12-13 | 1998-01-07 | 诺瓦蒂斯有限公司 | 速激肽拮抗剂 |
| JO2696B1 (en) * | 2002-12-23 | 2013-03-03 | شركة جانسين فارماسوتيكا ان. في | Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists |
| BRPI0510951A (pt) * | 2004-05-12 | 2007-11-20 | Pfizer Prod Inc | derivados de piperidina como antagonistas de nk1 e nk3 |
-
2008
- 2008-05-29 ES ES08760181T patent/ES2351378T3/es active Active
- 2008-05-29 JP JP2010510747A patent/JP2010529069A/ja active Pending
- 2008-05-29 AT AT08760181T patent/ATE486058T1/de active
- 2008-05-29 WO PCT/EP2008/056589 patent/WO2008148689A1/en not_active Ceased
- 2008-05-29 KR KR1020107000221A patent/KR101163292B1/ko not_active Expired - Fee Related
- 2008-05-29 MX MX2009013115A patent/MX2009013115A/es active IP Right Grant
- 2008-05-29 DE DE602008003221T patent/DE602008003221D1/de active Active
- 2008-05-29 CN CN2008800190899A patent/CN101679241B/zh not_active Expired - Fee Related
- 2008-05-29 AU AU2008258665A patent/AU2008258665B2/en not_active Ceased
- 2008-05-29 EP EP08760181A patent/EP2155672B1/en not_active Not-in-force
- 2008-05-29 CA CA002689560A patent/CA2689560A1/en not_active Abandoned
- 2008-05-29 BR BRPI0812447-7A2A patent/BRPI0812447A2/pt not_active IP Right Cessation
- 2008-05-30 US US12/129,718 patent/US7528136B2/en not_active Expired - Fee Related
-
2009
- 2009-11-19 IL IL202236A patent/IL202236A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602008003221D1 (de) | 2010-12-09 |
| ATE486058T1 (de) | 2010-11-15 |
| AU2008258665B2 (en) | 2012-07-05 |
| ES2351378T3 (es) | 2011-02-03 |
| US20080306086A1 (en) | 2008-12-11 |
| JP2010529069A (ja) | 2010-08-26 |
| EP2155672A1 (en) | 2010-02-24 |
| KR20100028629A (ko) | 2010-03-12 |
| CN101679241B (zh) | 2012-06-27 |
| IL202236A0 (en) | 2010-06-16 |
| US7528136B2 (en) | 2009-05-05 |
| BRPI0812447A2 (pt) | 2014-12-02 |
| WO2008148689A1 (en) | 2008-12-11 |
| KR101163292B1 (ko) | 2012-07-05 |
| CN101679241A (zh) | 2010-03-24 |
| EP2155672B1 (en) | 2010-10-27 |
| AU2008258665A1 (en) | 2008-12-11 |
| CA2689560A1 (en) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009013115A (es) | Derivados de prolinamida como antagonistas de nk3. | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| MX2010001774A (es) | Pirrolidin aril-eteres como antagonistas de receptores de nk3. | |
| PH12012500951A1 (en) | Substituted benzamide derivatives | |
| HRP20090235A2 (hr) | Karbonilirani (aza) cikloheksani kao ligandi dopaminskog receptora d<sub>3</sub> | |
| TNSN08372A1 (en) | Heterocyclic amides for use as pharmaceuticals | |
| MX354815B (es) | Derivados heterociclicos como receptores asociados con las aminas traza (taars). | |
| MX360667B (es) | Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5). | |
| SG195156A1 (en) | Pyrazole derivatives | |
| MX2010001080A (es) | Pirrolidin-aril-eteres como antagonistas de receptor de nk3. | |
| MX2009009384A (es) | Malonamidas como antagonistas de orexina. | |
| MX2009009121A (es) | Aminoamidas como antagonistas de orexina. | |
| PH12013501895A1 (en) | Ethynyl derivatives as positive allosteric modulators of the mglur5 | |
| ATE532780T1 (de) | Chinoline und ihre therapeutische verwendung | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| JP2013526610A5 (es) | ||
| MX2012008147A (es) | Derivados de pirrazolopiridina. | |
| MX2009010727A (es) | Heterociclos como antagonistas de orexina. | |
| PH12018500247A1 (en) | Ethynyl derivatives | |
| MX2012006293A (es) | Derivados de pirrolidina como antagonista del receptor nk-3. | |
| WO2008153902A2 (en) | Urotensin ii receptor antagonists | |
| PH12012502348A1 (en) | Novel spiroheterocyclic compounds as mglu5 antagonists | |
| MX2013007411A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2009006972A (es) | Derivados de espiropiperidina como antagonistas de neuroquinina 3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |